This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event August 16-18, 2022
In-Person: August 16-17 • Virtual: August 18Philadelphia, PA

Emad Samad
President at Octaviant Financial, Inc.


Mr. Samad is President of Octaviant Financial, Inc. Previous to Octaviant, Mr. Samad was a senior member of the investment banking team at WBB Securities where he focused his practice on strategic advisory, earning the trust of the executives he supported at the life sciences organizations he served and their investors. Mr. Samad has worked extensively on business transactions for life sciences and medical device companies, focused on structuring private and public equity financings and M&A transactions. During his tenure in banking, Mr. Samad advised immunotherapy, infectious disease, biodefense, gene and cell therapy, and regenerative medicine companies, and is the author of numerous publications on the subject of funding for biotechnology research in the United States.

Agenda Sessions

  • Drug Reimbursement Strategies for 21st Century Cures